(Q47803207)

5 February 2018

title

Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade (English)

1 reference

5 February 2018

main subject

essential hypertension

1 reference

Filigheddu F

1

1 reference

5 February 2018

Reid JE

2

1 reference

5 February 2018

Troffa C

3

1 reference

5 February 2018

PinnaParpaglia P

4

1 reference

5 February 2018

Argiolas G

5

1 reference

5 February 2018

Testa A

6

1 reference

5 February 2018

Skolnick M

7

1 reference

5 February 2018

Glorioso N

8

1 reference

5 February 2018

publication date

1 January 2004

1 reference

5 February 2018

The Pharmacogenomics Journal

published in

1 reference

5 February 2018

volume

4

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

154-160

1 reference

5 February 2018

Genetic dissection of complex traits

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Interaction of alpha(1)-Na,K-ATPase and Na,K,2Cl-cotransporter genes in human essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

The genomics of cardiovascular disorders: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

beta2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

The impact of JNC-VI guidelines on treatment recommendations in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Heterozygote advantage for HLA class-II type in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Myocardial infarction and thalassemia trait: an example of heterozygote advantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Polymorphism in regulatory gene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Relative efficacy of, and some adverse reactions to, different antihypertensive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Selectively enhanced cellular signaling by Gi proteins in essential hypertension. G alpha i2, G alpha i3, G beta 1, and G beta 2 are not mutated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Context-dependent genetic effects in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Replication validity of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Genetic analysis of Sardinia: I. data on 12 polymorphisms in 21 linguistic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

Polymorphism in the beta(1)-adrenergic receptor gene and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

Genetic variation in the beta-3-adrenergic receptor in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

Association of the G(s)alpha gene with essential hypertension and response to beta-blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

G-Protein β3 Subunit Gene ( GNB3 ) Variant in Causation of Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

The value of isolated populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

Statistical guidelines for contributors to medical journals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500247

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500247

1 reference

5 February 2018

1 reference

5 February 2018